In addition, SIRT3 might play a protective role in the glucose-deprivation-increased ROS levels, in particular mtROS, and in the glucose-deprivation-induced cell death of breast cancer cells with a high expression of xCT. This evidence concerns the gene SIRT3 and breast carcinoma.